Cargando…

Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial–mesenchymal transition in human hepatocellular carcinoma

Metastasis is the leading cause of death in patients with hepatocellular carcinoma (HCC) after curative resection. Therefore, it is critical to understand the mechanisms underlying tumor metastasis in HCC. We have previously shown that elevated expression of myeloid differentiation factor 88 (MyD88)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, R-J, Cao, L, Zhang, L, Jing, W, Chen, R, Zhu, M-H, Guo, S-W, Wu, G-B, Fan, X-Y, Wang, H, Zhang, Y-Y, Zhou, X-Y, Zhao, J, Guo, Y-J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973199/ https://www.ncbi.nlm.nih.gov/pubmed/24603331 http://dx.doi.org/10.1038/cddis.2014.71

Ejemplares similares

CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
por: Hu, J. L., et al.
Publicado: (2019)

A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer
por: Zhang, X, et al.
Publicado: (2017)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
por: Chen, Y-L, et al.
Publicado: (2013)

LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
por: Hou, P, et al.
Publicado: (2014)

LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition
por: Liu, Jie, et al.
Publicado: (2017)

DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis
por: Zhao, F, et al.
Publicado: (2015)

SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer
por: Zhao, X, et al.
Publicado: (2014)

Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling
por: Shi, Z-M, et al.
Publicado: (2017)

Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
por: Zhang, X, et al.
Publicado: (2016)

EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transition
por: Sun, M, et al.
Publicado: (2014)

Epithelial–mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer
por: Fan, X-J, et al.
Publicado: (2012)

Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
por: Li, Y-M, et al.
Publicado: (2013)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

Suppression of epithelial–mesenchymal transition and apoptotic pathways by miR-294/302 family synergistically blocks let-7-induced silencing of self-renewal in embryonic stem cells
por: Guo, W-T, et al.
Publicado: (2015)

The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
por: Chen, X, et al.
Publicado: (2013)

IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer
por: Zhu, S, et al.
Publicado: (2015)

TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
por: Wang, J, et al.
Publicado: (2014)

Integrated analyses identify the involvement of microRNA-26a in epithelial–mesenchymal transition during idiopathic pulmonary fibrosis
por: Liang, H, et al.
Publicado: (2014)

Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial–mesenchymal transition-induced angiogenesis
por: Li, C, et al.
Publicado: (2016)

LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway
por: Wang, X, et al.
Publicado: (2016)

STAT1/IFIT2 signaling pathway is involved in PD-L1-mediated epithelial-to-mesenchymal transition in human esophageal cancer
por: Chen, J., et al.
Publicado: (2022)

Detection of the mesenchymal-to-epithelial transition of invasive non-small cell lung cancer cells by their membrane undulation spectra
por: Hui, T. H., et al.
Publicado: (2020)

Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition
por: Behzatoglu, Kemal
Publicado: (2021)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)

LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer
por: Liu, Y-w, et al.
Publicado: (2015)

The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems
por: Leggett, Susan E., et al.
Publicado: (2021)

Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis
por: Xu, Q, et al.
Publicado: (2016)

TAp63 suppress metastasis via miR-133b in colon cancer cells
por: Lin, C W, et al.
Publicado: (2014)

miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells
por: Chen, Y, et al.
Publicado: (2013)

Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition
por: Xue, Tong-Chun, et al.
Publicado: (2014)

Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis
por: Cao, R, et al.
Publicado: (2014)

Response to comment on ‘TAp63 suppress metastasis via miR-133b in colon cancer cells'
por: Lin, C W, et al.
Publicado: (2014)

NKX6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial–mesenchymal transition
por: Li, H-J, et al.
Publicado: (2016)

The ERK–ZEB1 pathway mediates epithelial–mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids
por: Chiu, L-Y, et al.
Publicado: (2017)

WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition
por: Zhou, Yun, et al.
Publicado: (2016)

Knockdown of BAG3 induces epithelial–mesenchymal transition in thyroid cancer cells through ZEB1 activation
por: Meng, X, et al.
Publicado: (2014)

Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines
por: Xie, G, et al.
Publicado: (2014)

Salt-induced epithelial-to-mesenchymal transition in Dahl salt-sensitive rats is dependent on elevated blood pressure
por: Wang, Y., et al.
Publicado: (2014)

SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans
por: Zhang, L, et al.
Publicado: (2016)

Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria
por: Wang, Y, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_prjjfjoo6b5f26g3a5dtfo292q